A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection
Clinical trial NCT04198363 · COMPLETED
Trial details
- NCT number
- NCT04198363
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-30
- Primary completion
- 2021-11-01
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.